bremelanotide

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of ObesityNCT06565611PTNPhase 2Active not recruiting2025-02-05Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.